HF
YARW

HRT Financial’s Yarrow Bioscience YARW Stock Holding History

HRT Financial’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-551
Closed -$16K – 5466
2026
Q1 		$16K Buy
+551
New +$16.1K ﹤0.01% 3594
2025
Q3 		– Sell
-841
Closed -$69K – 3761
2025
Q2 		$69K Buy
841
+316
+60% +$20.5K ﹤0.01% 2266
2025
Q1 		$41K Buy
+525
New +$64.6K ﹤0.01% 2253
2024
Q1 		– Sell
-201
Closed -$23K – 3177
2023
Q4 		$23K Buy
+201
New +$31.3K ﹤0.01% 2028
2023
Q2 		– Sell
-206
Closed -$31K – 3367
2023
Q1 		$31K Buy
+206
New +$37K ﹤0.01% 2156
2022
Q2 		– Sell
-18
Closed -$10K – 3814
2022
Q1 		$10K Buy
+18
New +$10.7K ﹤0.01% 2899
2021
Q4 		– Sell
-87
Closed -$108K – 4177
2021
Q3 		$108K Sell
87
-29
-25% -$56.2K ﹤0.01% 2879
2021
Q2 		$366K Buy
+116
New +$459K ﹤0.01% 2019
2021
Q1 		– Sell
-3
Closed -$15K – 3203
2020
Q4 		$15K Buy
+3
New +$18.9K ﹤0.01% 1751

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HRT Financial's YARW Position: Q2 2026 in Review

HRT Financial sold out of Yarrow Bioscience (YARW) in Q2 2026, closing a stake of 551 shares — an estimated $16K sold.

HRT Financial first reported a position in YARW in Q4 2020 and held it in 9 quarters. The position peaked at $366K in Q2 2021. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • HRT Financial reported no remaining Yarrow Bioscience position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 551 Yarrow Bioscience shares in Q2 2026, an estimated $16K.
  • HRT Financial first reported a position in Yarrow Bioscience in Q4 2020 and held it in 9 quarters.
  • HRT Financial's Yarrow Bioscience position peaked at $366K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.